nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—CA14—seminal vesicle—testicular cancer	0.00889	0.12	CbGeAlD
Lacosamide—CA3—testis—testicular cancer	0.0051	0.0691	CbGeAlD
Lacosamide—CA9—testis—testicular cancer	0.00488	0.0662	CbGeAlD
Lacosamide—SCN9A—testis—testicular cancer	0.00454	0.0615	CbGeAlD
Lacosamide—CA5B—gonad—testicular cancer	0.00449	0.0609	CbGeAlD
Lacosamide—CA4—seminal vesicle—testicular cancer	0.00429	0.0582	CbGeAlD
Lacosamide—CA2—embryo—testicular cancer	0.00379	0.0514	CbGeAlD
Lacosamide—CA3—lymph node—testicular cancer	0.0037	0.0501	CbGeAlD
Lacosamide—CA2—seminal vesicle—testicular cancer	0.00356	0.0482	CbGeAlD
Lacosamide—SCN9A—lymph node—testicular cancer	0.00329	0.0446	CbGeAlD
Lacosamide—CA5B—testis—testicular cancer	0.00324	0.0439	CbGeAlD
Lacosamide—SCN3A—testis—testicular cancer	0.00315	0.0427	CbGeAlD
Lacosamide—CA4—female gonad—testicular cancer	0.00252	0.0342	CbGeAlD
Lacosamide—SCN10A—lymph node—testicular cancer	0.0025	0.0339	CbGeAlD
Lacosamide—CA5B—lymph node—testicular cancer	0.00235	0.0318	CbGeAlD
Lacosamide—SCN3A—lymph node—testicular cancer	0.00228	0.0309	CbGeAlD
Lacosamide—CA4—testis—testicular cancer	0.00224	0.0303	CbGeAlD
Lacosamide—Irritability—Methotrexate—testicular cancer	0.00221	0.00238	CcSEcCtD
Lacosamide—Dizziness—Vinblastine—testicular cancer	0.0022	0.00237	CcSEcCtD
Lacosamide—Mood swings—Methotrexate—testicular cancer	0.00219	0.00236	CcSEcCtD
Lacosamide—Ataxia—Methotrexate—testicular cancer	0.00217	0.00235	CcSEcCtD
Lacosamide—Diplopia—Epirubicin—testicular cancer	0.00216	0.00234	CcSEcCtD
Lacosamide—Osteoarthritis—Epirubicin—testicular cancer	0.00216	0.00234	CcSEcCtD
Lacosamide—Feeling abnormal—Dactinomycin—testicular cancer	0.00216	0.00233	CcSEcCtD
Lacosamide—Nausea—Chlorambucil—testicular cancer	0.00216	0.00233	CcSEcCtD
Lacosamide—Paraesthesia—Ifosfamide—testicular cancer	0.00216	0.00233	CcSEcCtD
Lacosamide—Anaemia—Etoposide—testicular cancer	0.00215	0.00232	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00214	0.00232	CcSEcCtD
Lacosamide—Somnolence—Ifosfamide—testicular cancer	0.00213	0.0023	CcSEcCtD
Lacosamide—Liver function test abnormal—Methotrexate—testicular cancer	0.00213	0.0023	CcSEcCtD
Lacosamide—Discomfort—Cisplatin—testicular cancer	0.00213	0.0023	CcSEcCtD
Lacosamide—Affect lability—Epirubicin—testicular cancer	0.00213	0.0023	CcSEcCtD
Lacosamide—Vomiting—Vinblastine—testicular cancer	0.00212	0.00228	CcSEcCtD
Lacosamide—CA2—female gonad—testicular cancer	0.00209	0.0283	CbGeAlD
Lacosamide—Vertigo—Etoposide—testicular cancer	0.00209	0.00225	CcSEcCtD
Lacosamide—Headache—Vinblastine—testicular cancer	0.00208	0.00225	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00208	0.00225	CcSEcCtD
Lacosamide—CA1—lymph node—testicular cancer	0.00207	0.0281	CbGeAlD
Lacosamide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00207	0.00224	CcSEcCtD
Lacosamide—Body temperature increased—Dactinomycin—testicular cancer	0.00207	0.00224	CcSEcCtD
Lacosamide—Fatigue—Ifosfamide—testicular cancer	0.00207	0.00224	CcSEcCtD
Lacosamide—Hypersensitivity—Bleomycin—testicular cancer	0.00207	0.00223	CcSEcCtD
Lacosamide—Constipation—Ifosfamide—testicular cancer	0.00205	0.00222	CcSEcCtD
Lacosamide—Mood swings—Epirubicin—testicular cancer	0.00205	0.00221	CcSEcCtD
Lacosamide—Loss of consciousness—Etoposide—testicular cancer	0.00204	0.0022	CcSEcCtD
Lacosamide—Ataxia—Epirubicin—testicular cancer	0.00203	0.0022	CcSEcCtD
Lacosamide—Nervous system disorder—Cisplatin—testicular cancer	0.00203	0.00219	CcSEcCtD
Lacosamide—Asthenia—Bleomycin—testicular cancer	0.00202	0.00218	CcSEcCtD
Lacosamide—Skin disorder—Cisplatin—testicular cancer	0.00201	0.00217	CcSEcCtD
Lacosamide—Diplopia—Doxorubicin—testicular cancer	0.002	0.00216	CcSEcCtD
Lacosamide—Osteoarthritis—Doxorubicin—testicular cancer	0.002	0.00216	CcSEcCtD
Lacosamide—Hyperhidrosis—Cisplatin—testicular cancer	0.002	0.00216	CcSEcCtD
Lacosamide—Liver function test abnormal—Epirubicin—testicular cancer	0.002	0.00216	CcSEcCtD
Lacosamide—Pruritus—Bleomycin—testicular cancer	0.00199	0.00215	CcSEcCtD
Lacosamide—Feeling abnormal—Ifosfamide—testicular cancer	0.00198	0.00214	CcSEcCtD
Lacosamide—Chest pain—Etoposide—testicular cancer	0.00198	0.00214	CcSEcCtD
Lacosamide—Eosinophilia—Methotrexate—testicular cancer	0.00198	0.00214	CcSEcCtD
Lacosamide—Nausea—Vinblastine—testicular cancer	0.00198	0.00213	CcSEcCtD
Lacosamide—Affect lability—Doxorubicin—testicular cancer	0.00197	0.00213	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00196	0.00212	CcSEcCtD
Lacosamide—Discomfort—Etoposide—testicular cancer	0.00195	0.00211	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00195	0.0021	CcSEcCtD
Lacosamide—Hypersensitivity—Dactinomycin—testicular cancer	0.00193	0.00208	CcSEcCtD
Lacosamide—Confusional state—Etoposide—testicular cancer	0.00191	0.00206	CcSEcCtD
Lacosamide—Urticaria—Ifosfamide—testicular cancer	0.00191	0.00206	CcSEcCtD
Lacosamide—Body temperature increased—Ifosfamide—testicular cancer	0.0019	0.00205	CcSEcCtD
Lacosamide—Mood swings—Doxorubicin—testicular cancer	0.0019	0.00205	CcSEcCtD
Lacosamide—Ataxia—Doxorubicin—testicular cancer	0.00188	0.00203	CcSEcCtD
Lacosamide—Asthenia—Dactinomycin—testicular cancer	0.00188	0.00203	CcSEcCtD
Lacosamide—Neutropenia—Methotrexate—testicular cancer	0.00187	0.00202	CcSEcCtD
Lacosamide—Paraesthesia—Cisplatin—testicular cancer	0.00186	0.00201	CcSEcCtD
Lacosamide—CA2—testis—testicular cancer	0.00185	0.0251	CbGeAlD
Lacosamide—Eosinophilia—Epirubicin—testicular cancer	0.00185	0.002	CcSEcCtD
Lacosamide—Liver function test abnormal—Doxorubicin—testicular cancer	0.00185	0.00199	CcSEcCtD
Lacosamide—Skin disorder—Etoposide—testicular cancer	0.00184	0.00199	CcSEcCtD
Lacosamide—Hyperhidrosis—Etoposide—testicular cancer	0.00183	0.00198	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.0018	0.00195	CcSEcCtD
Lacosamide—Diarrhoea—Dactinomycin—testicular cancer	0.00179	0.00194	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00179	0.00193	CcSEcCtD
Lacosamide—Vomiting—Bleomycin—testicular cancer	0.00179	0.00193	CcSEcCtD
Lacosamide—Depression—Methotrexate—testicular cancer	0.00178	0.00192	CcSEcCtD
Lacosamide—Rash—Bleomycin—testicular cancer	0.00177	0.00191	CcSEcCtD
Lacosamide—Dermatitis—Bleomycin—testicular cancer	0.00177	0.00191	CcSEcCtD
Lacosamide—Hypersensitivity—Ifosfamide—testicular cancer	0.00177	0.00191	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00177	0.00191	CcSEcCtD
Lacosamide—Neutropenia—Epirubicin—testicular cancer	0.00175	0.00189	CcSEcCtD
Lacosamide—Asthenia—Ifosfamide—testicular cancer	0.00172	0.00186	CcSEcCtD
Lacosamide—Eosinophilia—Doxorubicin—testicular cancer	0.00171	0.00185	CcSEcCtD
Lacosamide—Feeling abnormal—Cisplatin—testicular cancer	0.00171	0.00184	CcSEcCtD
Lacosamide—Paraesthesia—Etoposide—testicular cancer	0.0017	0.00184	CcSEcCtD
Lacosamide—Pruritus—Ifosfamide—testicular cancer	0.0017	0.00183	CcSEcCtD
Lacosamide—Somnolence—Etoposide—testicular cancer	0.00169	0.00182	CcSEcCtD
Lacosamide—Hepatobiliary disease—Methotrexate—testicular cancer	0.00168	0.00182	CcSEcCtD
Lacosamide—Nausea—Bleomycin—testicular cancer	0.00167	0.0018	CcSEcCtD
Lacosamide—Vomiting—Dactinomycin—testicular cancer	0.00167	0.0018	CcSEcCtD
Lacosamide—Agranulocytosis—Methotrexate—testicular cancer	0.00166	0.00179	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00165	0.00178	CcSEcCtD
Lacosamide—Rash—Dactinomycin—testicular cancer	0.00165	0.00178	CcSEcCtD
Lacosamide—Diarrhoea—Ifosfamide—testicular cancer	0.00164	0.00177	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.00164	0.00177	CcSEcCtD
Lacosamide—Body temperature increased—Cisplatin—testicular cancer	0.00164	0.00177	CcSEcCtD
Lacosamide—Fatigue—Etoposide—testicular cancer	0.00163	0.00177	CcSEcCtD
Lacosamide—Constipation—Etoposide—testicular cancer	0.00162	0.00175	CcSEcCtD
Lacosamide—CA4—lymph node—testicular cancer	0.00162	0.022	CbGeAlD
Lacosamide—Neutropenia—Doxorubicin—testicular cancer	0.00162	0.00175	CcSEcCtD
Lacosamide—Hepatitis—Methotrexate—testicular cancer	0.0016	0.00173	CcSEcCtD
Lacosamide—Dizziness—Ifosfamide—testicular cancer	0.00159	0.00171	CcSEcCtD
Lacosamide—Hepatobiliary disease—Epirubicin—testicular cancer	0.00158	0.0017	CcSEcCtD
Lacosamide—Feeling abnormal—Etoposide—testicular cancer	0.00156	0.00169	CcSEcCtD
Lacosamide—Nausea—Dactinomycin—testicular cancer	0.00156	0.00168	CcSEcCtD
Lacosamide—Agranulocytosis—Epirubicin—testicular cancer	0.00156	0.00168	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00153	0.00165	CcSEcCtD
Lacosamide—Vomiting—Ifosfamide—testicular cancer	0.00153	0.00165	CcSEcCtD
Lacosamide—Hypersensitivity—Cisplatin—testicular cancer	0.00153	0.00165	CcSEcCtD
Lacosamide—Bradycardia—Epirubicin—testicular cancer	0.00152	0.00164	CcSEcCtD
Lacosamide—Rash—Ifosfamide—testicular cancer	0.00151	0.00163	CcSEcCtD
Lacosamide—Dermatitis—Ifosfamide—testicular cancer	0.00151	0.00163	CcSEcCtD
Lacosamide—Erythema multiforme—Methotrexate—testicular cancer	0.00151	0.00163	CcSEcCtD
Lacosamide—Urticaria—Etoposide—testicular cancer	0.00151	0.00163	CcSEcCtD
Lacosamide—Body temperature increased—Etoposide—testicular cancer	0.0015	0.00162	CcSEcCtD
Lacosamide—Hepatitis—Epirubicin—testicular cancer	0.0015	0.00162	CcSEcCtD
Lacosamide—Eye disorder—Methotrexate—testicular cancer	0.00149	0.00161	CcSEcCtD
Lacosamide—Tinnitus—Methotrexate—testicular cancer	0.00149	0.00161	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—testicular cancer	0.00149	0.00161	CcSEcCtD
Lacosamide—Asthenia—Cisplatin—testicular cancer	0.00149	0.0016	CcSEcCtD
Lacosamide—Cardiac disorder—Methotrexate—testicular cancer	0.00148	0.0016	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—testicular cancer	0.00147	0.00159	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00146	0.00157	CcSEcCtD
Lacosamide—Immune system disorder—Methotrexate—testicular cancer	0.00144	0.00156	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—testicular cancer	0.00144	0.00155	CcSEcCtD
Lacosamide—Nausea—Ifosfamide—testicular cancer	0.00143	0.00154	CcSEcCtD
Lacosamide—Diarrhoea—Cisplatin—testicular cancer	0.00142	0.00153	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—testicular cancer	0.00141	0.00153	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—testicular cancer	0.00141	0.00152	CcSEcCtD
Lacosamide—Mental disorder—Methotrexate—testicular cancer	0.0014	0.00151	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—testicular cancer	0.0014	0.00151	CcSEcCtD
Lacosamide—Hypersensitivity—Etoposide—testicular cancer	0.0014	0.00151	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—testicular cancer	0.0014	0.00151	CcSEcCtD
Lacosamide—Erythema—Methotrexate—testicular cancer	0.00139	0.0015	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—testicular cancer	0.00139	0.0015	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—testicular cancer	0.00138	0.00149	CcSEcCtD
Lacosamide—Hypoaesthesia—Doxorubicin—testicular cancer	0.00138	0.00149	CcSEcCtD
Lacosamide—Asthenia—Etoposide—testicular cancer	0.00136	0.00147	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—testicular cancer	0.00136	0.00147	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—testicular cancer	0.00135	0.00146	CcSEcCtD
Lacosamide—CA2—lymph node—testicular cancer	0.00134	0.0182	CbGeAlD
Lacosamide—Pruritus—Etoposide—testicular cancer	0.00134	0.00145	CcSEcCtD
Lacosamide—Vomiting—Cisplatin—testicular cancer	0.00132	0.00142	CcSEcCtD
Lacosamide—Vision blurred—Methotrexate—testicular cancer	0.00131	0.00142	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—testicular cancer	0.00131	0.00142	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—testicular cancer	0.00131	0.00141	CcSEcCtD
Lacosamide—Rash—Cisplatin—testicular cancer	0.00131	0.00141	CcSEcCtD
Lacosamide—Dermatitis—Cisplatin—testicular cancer	0.0013	0.00141	CcSEcCtD
Lacosamide—Erythema—Epirubicin—testicular cancer	0.0013	0.00141	CcSEcCtD
Lacosamide—Diarrhoea—Etoposide—testicular cancer	0.0013	0.0014	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—testicular cancer	0.00129	0.0014	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—testicular cancer	0.00129	0.00139	CcSEcCtD
Lacosamide—Anaemia—Methotrexate—testicular cancer	0.00129	0.00139	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—testicular cancer	0.00128	0.00139	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—testicular cancer	0.00128	0.00139	CcSEcCtD
Lacosamide—Dizziness—Etoposide—testicular cancer	0.00125	0.00135	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—testicular cancer	0.00125	0.00135	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—testicular cancer	0.00125	0.00135	CcSEcCtD
Lacosamide—Vertigo—Methotrexate—testicular cancer	0.00125	0.00135	CcSEcCtD
Lacosamide—Nausea—Cisplatin—testicular cancer	0.00123	0.00133	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—testicular cancer	0.00123	0.00133	CcSEcCtD
Lacosamide—Mental disorder—Doxorubicin—testicular cancer	0.00121	0.00131	CcSEcCtD
Lacosamide—Vomiting—Etoposide—testicular cancer	0.00121	0.0013	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—testicular cancer	0.00121	0.0013	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—testicular cancer	0.0012	0.0013	CcSEcCtD
Lacosamide—Agitation—Epirubicin—testicular cancer	0.0012	0.00129	CcSEcCtD
Lacosamide—Rash—Etoposide—testicular cancer	0.0012	0.00129	CcSEcCtD
Lacosamide—Dermatitis—Etoposide—testicular cancer	0.00119	0.00129	CcSEcCtD
Lacosamide—Headache—Etoposide—testicular cancer	0.00119	0.00128	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—testicular cancer	0.00119	0.00128	CcSEcCtD
Lacosamide—Chest pain—Methotrexate—testicular cancer	0.00118	0.00128	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00118	0.00127	CcSEcCtD
Lacosamide—Discomfort—Methotrexate—testicular cancer	0.00117	0.00126	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—testicular cancer	0.00117	0.00126	CcSEcCtD
Lacosamide—Syncope—Epirubicin—testicular cancer	0.00117	0.00126	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—testicular cancer	0.00116	0.00125	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—testicular cancer	0.00115	0.00124	CcSEcCtD
Lacosamide—Confusional state—Methotrexate—testicular cancer	0.00115	0.00124	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—testicular cancer	0.00114	0.00124	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—testicular cancer	0.00114	0.00123	CcSEcCtD
Lacosamide—Nausea—Etoposide—testicular cancer	0.00113	0.00122	CcSEcCtD
Lacosamide—Nervous system disorder—Methotrexate—testicular cancer	0.00111	0.0012	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—testicular cancer	0.00111	0.0012	CcSEcCtD
Lacosamide—Chest pain—Epirubicin—testicular cancer	0.00111	0.0012	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—testicular cancer	0.00111	0.0012	CcSEcCtD
Lacosamide—Skin disorder—Methotrexate—testicular cancer	0.0011	0.00119	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.0011	0.00119	CcSEcCtD
Lacosamide—Hyperhidrosis—Methotrexate—testicular cancer	0.0011	0.00119	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—testicular cancer	0.0011	0.00118	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—testicular cancer	0.00108	0.00117	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—testicular cancer	0.00108	0.00117	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—testicular cancer	0.00108	0.00117	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—testicular cancer	0.00107	0.00116	CcSEcCtD
Lacosamide—Palpitations—Doxorubicin—testicular cancer	0.00107	0.00115	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—testicular cancer	0.00106	0.00114	CcSEcCtD
Lacosamide—Shock—Epirubicin—testicular cancer	0.00105	0.00113	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—testicular cancer	0.00104	0.00113	CcSEcCtD
Lacosamide—Skin disorder—Epirubicin—testicular cancer	0.00103	0.00111	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—testicular cancer	0.00103	0.00111	CcSEcCtD
Lacosamide—Insomnia—Methotrexate—testicular cancer	0.00103	0.00111	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—testicular cancer	0.00103	0.00111	CcSEcCtD
Lacosamide—Paraesthesia—Methotrexate—testicular cancer	0.00102	0.0011	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00102	0.0011	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—testicular cancer	0.00101	0.00109	CcSEcCtD
Lacosamide—Somnolence—Methotrexate—testicular cancer	0.00101	0.00109	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—testicular cancer	0.001	0.00108	CcSEcCtD
Lacosamide—Dyspepsia—Methotrexate—testicular cancer	0.001	0.00108	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—testicular cancer	0.000992	0.00107	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000981	0.00106	CcSEcCtD
Lacosamide—Fatigue—Methotrexate—testicular cancer	0.000979	0.00106	CcSEcCtD
Lacosamide—Shock—Doxorubicin—testicular cancer	0.000968	0.00104	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—testicular cancer	0.000965	0.00104	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—testicular cancer	0.000961	0.00104	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—testicular cancer	0.000955	0.00103	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—testicular cancer	0.000955	0.00103	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000951	0.00103	CcSEcCtD
Lacosamide—Somnolence—Epirubicin—testicular cancer	0.000945	0.00102	CcSEcCtD
Lacosamide—Feeling abnormal—Methotrexate—testicular cancer	0.000936	0.00101	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—testicular cancer	0.000936	0.00101	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000918	0.000991	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—testicular cancer	0.000916	0.000989	CcSEcCtD
Lacosamide—Constipation—Epirubicin—testicular cancer	0.000909	0.000981	CcSEcCtD
Lacosamide—Urticaria—Methotrexate—testicular cancer	0.000902	0.000974	CcSEcCtD
Lacosamide—Body temperature increased—Methotrexate—testicular cancer	0.000898	0.000969	CcSEcCtD
Lacosamide—Insomnia—Doxorubicin—testicular cancer	0.00089	0.00096	CcSEcCtD
Lacosamide—Paraesthesia—Doxorubicin—testicular cancer	0.000883	0.000954	CcSEcCtD
Lacosamide—Feeling abnormal—Epirubicin—testicular cancer	0.000876	0.000946	CcSEcCtD
Lacosamide—Somnolence—Doxorubicin—testicular cancer	0.000874	0.000944	CcSEcCtD
Lacosamide—Dyspepsia—Doxorubicin—testicular cancer	0.000866	0.000935	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000849	0.000917	CcSEcCtD
Lacosamide—Fatigue—Doxorubicin—testicular cancer	0.000848	0.000916	CcSEcCtD
Lacosamide—Urticaria—Epirubicin—testicular cancer	0.000844	0.000912	CcSEcCtD
Lacosamide—Constipation—Doxorubicin—testicular cancer	0.000841	0.000908	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—testicular cancer	0.00084	0.000907	CcSEcCtD
Lacosamide—Hypersensitivity—Methotrexate—testicular cancer	0.000837	0.000904	CcSEcCtD
Lacosamide—Asthenia—Methotrexate—testicular cancer	0.000815	0.00088	CcSEcCtD
Lacosamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000811	0.000875	CcSEcCtD
Lacosamide—Pruritus—Methotrexate—testicular cancer	0.000804	0.000868	CcSEcCtD
Lacosamide—Hypersensitivity—Epirubicin—testicular cancer	0.000783	0.000846	CcSEcCtD
Lacosamide—Urticaria—Doxorubicin—testicular cancer	0.000781	0.000844	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—testicular cancer	0.000778	0.000839	CcSEcCtD
Lacosamide—Diarrhoea—Methotrexate—testicular cancer	0.000777	0.000839	CcSEcCtD
Lacosamide—Asthenia—Epirubicin—testicular cancer	0.000763	0.000823	CcSEcCtD
Lacosamide—Pruritus—Epirubicin—testicular cancer	0.000752	0.000812	CcSEcCtD
Lacosamide—Dizziness—Methotrexate—testicular cancer	0.000751	0.000811	CcSEcCtD
Lacosamide—Diarrhoea—Epirubicin—testicular cancer	0.000727	0.000785	CcSEcCtD
Lacosamide—Hypersensitivity—Doxorubicin—testicular cancer	0.000725	0.000782	CcSEcCtD
Lacosamide—Vomiting—Methotrexate—testicular cancer	0.000722	0.00078	CcSEcCtD
Lacosamide—Rash—Methotrexate—testicular cancer	0.000716	0.000773	CcSEcCtD
Lacosamide—Dermatitis—Methotrexate—testicular cancer	0.000716	0.000773	CcSEcCtD
Lacosamide—Headache—Methotrexate—testicular cancer	0.000712	0.000768	CcSEcCtD
Lacosamide—Asthenia—Doxorubicin—testicular cancer	0.000706	0.000762	CcSEcCtD
Lacosamide—Dizziness—Epirubicin—testicular cancer	0.000703	0.000759	CcSEcCtD
Lacosamide—Pruritus—Doxorubicin—testicular cancer	0.000696	0.000751	CcSEcCtD
Lacosamide—Vomiting—Epirubicin—testicular cancer	0.000676	0.00073	CcSEcCtD
Lacosamide—Nausea—Methotrexate—testicular cancer	0.000675	0.000728	CcSEcCtD
Lacosamide—Diarrhoea—Doxorubicin—testicular cancer	0.000673	0.000727	CcSEcCtD
Lacosamide—Rash—Epirubicin—testicular cancer	0.00067	0.000724	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—testicular cancer	0.00067	0.000723	CcSEcCtD
Lacosamide—Headache—Epirubicin—testicular cancer	0.000666	0.000719	CcSEcCtD
Lacosamide—Dizziness—Doxorubicin—testicular cancer	0.00065	0.000702	CcSEcCtD
Lacosamide—Nausea—Epirubicin—testicular cancer	0.000631	0.000682	CcSEcCtD
Lacosamide—Vomiting—Doxorubicin—testicular cancer	0.000625	0.000675	CcSEcCtD
Lacosamide—Rash—Doxorubicin—testicular cancer	0.00062	0.00067	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—testicular cancer	0.00062	0.000669	CcSEcCtD
Lacosamide—Headache—Doxorubicin—testicular cancer	0.000616	0.000665	CcSEcCtD
Lacosamide—Nausea—Doxorubicin—testicular cancer	0.000584	0.000631	CcSEcCtD
